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Background: Bacterial pathogenicity represents a major public health concern worldwide. Secretion systems are a
key component of bacterial pathogenicity, as they provide the means for bacterial proteins to penetrate host-cell
membranes and insert themselves directly into the host cells’ cytosol. Burkholderia mallei is a Gram-negative bacterium
that uses multiple secretion systems during its host infection life cycle. To date, the identities of secretion system proteins
for B. mallei are not well known, and their pathogenic mechanisms of action and host factors are largely uncharacterized.
Description: We present the Database of Burkholderia mallei Secretion Systems (DBSecSys), a compilation of manually
curated and computationally predicted bacterial secretion system proteins and their host factors. Currently, DBSecSys
contains comprehensive experimentally and computationally derived information about B. mallei strain ATCC 23344.
The database includes 143 B. mallei proteins associated with five secretion systems, their 1,635 human and murine
interacting targets, and the corresponding 2,400 host-B. mallei interactions. The database also includes information
about 10 pathogenic mechanisms of action for B. mallei secretion system proteins inferred from the available literature.
Additionally, DBSecSys provides details about 42 virulence attenuation experiments for 27 B. mallei secretion system
proteins. Users interact with DBSecSys through a Web interface that allows for data browsing, querying, visualizing,
and downloading.
Conclusions: DBSecSys provides a comprehensive, systematically organized resource of experimental and
computational data associated with B. mallei secretion systems. It provides the unique ability to study secretion
systems not only through characterization of their corresponding pathogen proteins, but also through characterization
of their host-interacting partners.
The database is available at https://applications.bhsai.org/dbsecsys.
Keywords: Bacterial secretion system, Virulence factors, Pathogenic mechanisms of action, Host-pathogen interactions,
Burkholderia malleiBackground
Introduction
Pathogenic bacteria cause a variety of diseases and repre-
sent a major public health concern worldwide. Secretion
systems are a key component of bacterial pathogenicity, as
they facilitate pathogenic internalization, survival, and rep-
lication within host cells through controlled transport and
translocation of pathogenic molecules, e.g., proteins or* Correspondence: jaques.reifman.civ@mail.mil
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article, unless otherwise stated.DNA, from the interior of the bacterial cell into the host
cell’s cytosol [1,2]. Bacterial species frequently contain
more than one type of secretion system, and some secre-
tion systems are often encoded in multiple gene clusters
(also called pathogenicity islands) [3-7].
The Gram-negative bacterium Burkholderia mallei,
the causative agent of glanders, uses a variety of special-
ized secretion systems to interfere with host defense
mechanisms and promote pathogen colonization. Given
its ability to infect hosts via aerosol exposure, consider-
able antibiotic resistance, and the lack of a vaccine,
B. mallei represents an emerging public health threat
[8]. While the research into B. mallei pathogenicity has
recently expanded, the identities of all of its secretiontral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Summary of the current content of DBSecSys
Number of B. mallei
proteins 143
virulence factors 21
virulence attenuation experiments 42
associated secretion systems 5





Number of protein-protein interactions
human-B. mallei (experimental) 569
murine-B. mallei (experimental) 788
human-B. mallei (computational) 608
murine-B. mallei (computational) 435
human-human (experimental) 491
murine-murine (experimental) 36
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pathogenic mechanisms are largely unknown.
To date, several database systems provide information
about Burkholderia species proteins. Some provide gen-
eral B. mallei protein information [9,10], such as se-
quence annotation, naming schemes, and functional and
pathway associations, but such systems lack systematic
organization of the pathogen proteins that are part of se-
cretion systems. Other databases are more specific and
encompass information about single [11-13] or multiple
[14-16] bacterial secretion systems for many, but not all,
Burkholderia species. While these databases provide a
useful characterization of proteins based on the secre-
tion system type, they lack information about pathogenic
mechanisms of action associated with secretion systems
and their host targets.
Our contribution
As none of the available secretion system databases
includes B. mallei secretion systems data, the goal of
the Database of Burkholderia mallei Secretion Systems
(DBSecSys) is to provide information about B. mallei
(strain ATCC 23344) proteins associated with secretion
systems and their host factors. Currently, DBSecSys con-
tains experimentally and computationally derived infor-
mation about B. mallei proteins associated with secretion
systems. The information includes their secretion system
types, involvement in virulence, associated mechanisms
of action, host targets (interacting host proteins), and
general annotation (assigned names and IDs, protein se-
quence, and functional and pathway association). These
features provide researchers with the unique ability to
study B. mallei pathogenicity and secretion systems not
only through characterization of the corresponding patho-




Table 1 summarizes the content of DBSecSys. Using the
available literature on Burkholderia species, we manually
compiled a list of B. mallei proteins and their associated
secretion systems. The resulting list contains five secretion
system types associated with 143 B. mallei proteins, where
each protein is associated with only one secretion system
type. Additionally, as represented in DBSecSys, the list
contains the available information about gene clusters as-
sociated with secretion systems, protein descriptions, and
secretion system protein characterizations, e.g., effector or
secretion apparatus proteins. B. mallei secretion system
proteins are also characterized based on their association
with one of 10 inferred pathogenic mechanisms of action.
In addition to pathogen proteins, DBSecSys contains
information on 1,635 host (797 human and 838 murine)proteins, as well as information on 2,400 host-pathogen
interactions between B. mallei and host proteins. Of
these, 1,357 interactions have been detected experimen-
tally: 569 human-B. mallei and 788 murine-B. mallei
interactions. The remaining interactions (608 human-
B. mallei and 435 murine-B. mallei interactions), have
been determined computationally based on orthology
between human and murine proteins provided in the
National Center for Biotechnology Information (NCBI)
HomoloGene database [17,18]. In addition, DBSecSys con-
tains a set of 491 protein-protein interactions (PPIs) [19]
among 357 human proteins that interact with B. mallei,
and 36 PPIs [20,21] among 47 murine proteins that inter-
act with B. mallei.
DBSecSys also provides information about 42 viru-
lence attenuation (by genetic ablation) experiments for
27 of the 143 listed B. mallei proteins (21 of which are
virulence factors). This information includes seven infec-
tion delivery routes, eight animal models used, and four
observed virulence attenuation levels (full, moderate, mild,
or no attenuation).
DBSecSys uses a standard nomenclature to describe
secretion systems (see Table 2) and commonly used lit-
erature terms to define pathogenic mechanisms of action
(see Table 3). All data in the database can be tracked to
their experimental or computational source.
Data sources
The list of B. mallei proteins associated with each secretion
system was compiled using the results of B. mallei experi-
mental studies [22-24], computational predictions based
on orthology, and de-novo computational predictions. We
Table 2 Description of secretion systems
Secretion system type Description
1* - Consists of three protein subunits: the ATP-binding cassette (ABC) transporters, membrane fusion proteins, and outer
membrane proteins.
- Transports various proteins, e.g., RTX toxins and the lipases, as well as non-proteinaceous substrates, e.g., cyclic β-glucans
and polysaccharides.
2* - Represents a Sec/Tat-dependent system, as proteins that pass through this system must first reach the periplasm via
either the general secretion route (Sec pathway) or the twin-arginine translocation pathway (Tat-pathway).
- Sometimes used by Gram-negative bacteria type IV pili for their biogenesis.
3* - Consists of machinery proteins (called injectisomes) and proteins that are secreted into a host cell (called effectors).
- Sometimes consists of two or more gene clusters (pathogenicity islands).
- Found in Gram-negative bacteria that interact with both plant and animal hosts.
4 - Can be divided into three types: 1) a type IVA secretion system resembling the archetypal VirB/VirD4 system and
consisting of conjugative plasmids F and RP4 (IncF and IncP); 2) a type IVB secretion system also known as the
intracellular multiplication/defect in organelle trafficking genes (icm/dot) system, consisting of conjugative plasmid R64;
and 3) a GI type that is, so far, associated exclusively with genomic islands.
- Evolutionarily related to bacterial conjugation systems and capable of transporting both proteins and nucleic acids into
host cells, as well as into other bacteria.
5* - Also known as the autotransporter system.
- Can be divided into three types: 1) the archetypal bacterial proteins exported into the periplasm via the Sec system;
2) trimeric proteins with a single beta barrel domain; and 3) pairs of proteins in which one partner carries the beta barrel
domain and the other partner is the secreted protein.
6* - Consists of machinery proteins (called injectisomes) and proteins that are secreted into a host cell (called effectors).
- Sometimes consists of two or more gene clusters (pathogenicity islands).
- Nearly universally secretes two proteins: Hcp and VgrG.
7 - Used for the transport of extracellular proteins across the Gram-positive bacteria cell wall.
- Often encoded in two or more gene clusters (pathogenicity islands).
*Associated with B. mallei (strain ATCC 23344) and included in DBSecSys.
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secretion systems based on the results of B. pseudomallei
experimental studies, as these two species share a large
number of genes with high sequence similarity [22-27]. We
used only a subset of predicted B. mallei secretion systemTable 3 Description of pathogenic mechanisms of action inclu
Name Pathogens use this m
Actin cytoskeleton rearrangement Subvert the host cell cy
the host cell, and to pr
Actin-based motility Bind to host actin, trigg
mechanical force that p
Adhesion Attach to host cell surfa
Apoptosis Exert control on the pr
Interference with signaling Interfere with host sign
intracellular survival.
Interference with the immune response Down-regulate host inf
and intracellular surviva
Invasion Promote their ability to
Multi-nucleated giant cell formation Induce host cell fusion
Phagosomal escape and evasion of autophagy Ensure bacterial escape
the pathogens’ intracel
Ubiquitination - deubiquitination Interfere with host ubiqu
degradation, and to ensproteins that has been shown to interact with host proteins
experimentally [28].
Twenty-four B. mallei proteins associated with secre-
tion systems participate in PPIs with human and murine
hosts [28]. Given that the PPI detection experiments didded in DBSecSys
echanism to:
toskeleton to promote attachment to host cell surface, internalization in
event uptake by phagocytic cells.
ering actin polymerization on the pathogens’ surface and producing a
ropels them through the host cell and facilitates cell-to-cell spread.
ce, promoting bacterial internalization in the host cell.
ocesses that regulate apoptosis in the host.
aling cascade, promoting their internalization in the host cell and
lammatory responses, promoting their internalization in the host cell
l.
invade the host cell.
and multi-nucleated giant cell formation.
from endocytic vesicles, as well as to evade autophagosome, ensuring
lular survival and cell-to-cell spread.
itination processes to attenuate host immune response, to prevent their
ure their destruction when no longer required for establishing the infection.
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interactions, we used human-murine orthology informa-
tion [17,18] to infer additional interactions. This proced-
ure generated a list of experimentally and computationally
identified human- and murine-B. mallei PPIs associated
with secretion systems. Furthermore, to account for the re-
lationship among host proteins that interact with B. mallei
proteins, we used information from host PPI networks. For
human PPIs, we used data from an experimentally detected
PPI network compiled by Yu et al. [19], while for murine
PPIs, we used data from an experimentally detected
PPI network available in the BIOGRID database (Release
3.2.105) [20,21].
We compiled the list of B. mallei pathogenic mecha-
nisms of action based on the results of B. mallei experi-
mental studies [22,29] and the computational predictions
using orthology and host-pathogen PPI data. We used
information about orthology between B. mallei and
B. pseudomallei proteins to infer mechanisms of action
experimentally identified for B. pseudomallei [30-32]. We
inferred B. mallei mechanisms of action from host-
pathogen PPIs as follows. First, we surveyed the available
pathogenicity literature for associations between specific
host protein functions and pathogenic mechanisms of ac-
tion. Then, for each pathogenic mechanism of action, we
compiled a set of its corresponding host proteins' func-
tions. Next, for each B. mallei protein present in host-
B. mallei PPI data [28], we counted the number of its
host-interacting partners that were annotated with at
least one function associated with each of the mechanisms.
If a B. mallei protein interacted with≥ 3 host proteins that
corresponded to a single mechanism, we assigned the pro-
tein to that mechanism of action.
Finally, using literature information, we manually com-
piled a list of B. mallei secretion system proteins that
have been experimentally evaluated for virulence attenu-
ation (by genetic ablation) in an animal model. The list
contains proteins identified in B. mallei studies [28] and
proteins computationally inferred from B. pseudomallei
studies using orthology information [30,33,34].
We used NCBI [17,18] and Uniprot [35] to annotate
pathogen and host proteins, e.g., protein names and se-
quence information. For functional annotation of host
proteins, we used Gene Ontology (GO) terms [36] and
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways [37,38].
Software architecture
We developed the DBSecSys database and Web interface
using a three-tier architecture comprising a backend
database, controller, and presentation tiers. The first tier
consists of an Oracle database server that stores the data
contained in the DBSecSys database using a relational
schema. We developed the controller and presentationtiers using Java Platform, Enterprise Edition 7, JavaServer
Faces 2, and ICEfaces 3 technologies. The presentation
tier comprising a Web interface also uses JBrowse
[39-41], D3.js [42], NVD3.js [43], and Cytoscape.js [44]
JavaScript libraries to create detailed interactive visuali-
zations of genes on the reference sequence and of
protein-protein interactions. All visualizations are based
on modern Web standards and do not require any plu-
gins. The DBSecSys Web application is hosted on an
Apache Tomcat Web server at: https://applications.bhsai.
org/dbsecsys.
Utility and discussion
At its core, DBSecSys contains information about B. mallei
secretion system proteins, their inferred pathogenic mech-
anisms of action, host protein interacting partners, and
virulence attenuation experiments. A Web-based graph-
ical user interface presents the DBSecSys data with
interactive search and visualization capabilities. It pro-
vides the ability to browse, query, and visualize these
data in multiple ways, allowing users to explore secre-
tion systems through pathogen proteins, as well as their
host-interacting partners (Figures 1 and 2). All data
within DBSecSys are cross-linked. This feature facilitates ef-
ficient navigation between different DBSecSys pages. It also
allows users to apply retrieved results as queries for new
searches, minimizing the need to navigate to a designated
query page. DBSecSys query results can be filtered and
downloaded in a tab-delimited format. Host-pathogen PPIs
are available for download in the Proteomics Standards
Initiative Molecular Interactions (PSI-MI) Tab 2.5 format
[45]. DBSecSys also provides links to external resources for
detailed information about individual proteins (NCBI
[17,18], Uniprot [35], GO [36], and KEGG [37,38]). For all
experimental data and observations contained in the data-
base, DBSecSys provides links to their original sources and
publications through PubMed.
DBSecSys queries are anchored around five applications
(Figure 1), which search for 1) pathogen protein or host
protein annotation, 2) all pathogen proteins associated
with a secretion system, 3) all pathogen proteins associ-
ated with the pathogen’s mechanism of action, 4) host-
pathogen interactions, and 5) experimentally screened
virulence factors.
Application 1: Study of individual proteins
Users can study individual (pathogen or host) proteins
on the “Proteins” page of the Web interface. For ex-
ample, users can search either for a B. mallei protein to
determine its association with a secretion system, or for
a host (human or murine) protein to determine whether
it interacts with a pathogen protein associated with a se-
cretion system. Protein searches can be performed using
one of the following known protein/gene identifiers: Locus
Figure 1 DBSecSys home page. The Web interface of DBSecSys provides features for browsing, querying, visualizing, and downloading detailed
information about Burkholderia mallei (strain ATCC 23344) proteins associated with secretion systems, their involvement in virulence, their host
protein targets, and their mechanisms of action inferred from host-pathogen interaction data and literature review.
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Identifier (GI), and KEGG ID.
When the query protein is represented in the database,
DBSecSys returns its detailed annotation information,
including protein/gene identifiers from different annota-
tion databases (see above), chromosomal location, amino
acid sequence information, and corresponding GO [36]
and KEGG [37,38] annotations. All annotation informa-
tion is linked with its external source. If the host-B. mallei
interactions data is available for the queried protein,
DBSecSys provides a list of host-pathogen PPIs for that
protein. Additionally, if the queried protein is a pathogen
protein, the database provides information about its asso-
ciated secretion system, inferred mechanisms of action,
and, if it was tested for virulence attenuation, information
about its effect on virulence. Conversely, if the queried
protein is a host protein, DBSecSys provides information
about pathogen proteins that target this host protein, e.g.,
the secretion systems with which they are associated and
their inferred mechanisms of action.
Application 2: Study of pathogen proteins associated
with a secretion system
Users can study pathogen proteins associated with a spe-
cific secretion system on the “Secretion Systems” page of
the Web interface. This page allows users to select one
of the secretion systems associated with B. mallei andlist all pathogen proteins associated with it. DBSecSys
retrieves a list of B. mallei proteins associated with the
queried secretion system and the information about
their role, the pathogenicity island/cluster type (for the
secretion systems that are encoded in two or more gene
clusters), details about their associated mechanism(s) of
action, and details about the corresponding virulence at-
tenuation experiments. If host-B. mallei interaction data
are available for the listed B. mallei proteins, DBSecSys
also retrieves the corresponding host-pathogen PPIs.
Users have the option to filter the retrieved list of pro-
teins based on a secretion system cluster or a mechan-
ism of action. DBSecSys also filters the corresponding
list of host-pathogen PPIs, ensuring that it contains only
proteins that satisfy user-specified criteria (filters).
Figure 2A shows a list of proteins associated with the
type 3 secretion system that are filtered based on the
cluster type (animal-associated cluster) and the mechanism
of action association (actin cytoskeleton rearrangement),
while Figure 2B and C show visualization options for pro-
teins associated with secretion system clusters and their as-
sociated host-pathogen PPIs, respectively.
Application 3: Study of pathogen proteins associated
with an inferred pathogenic mechanism of action
Users can also study pathogen proteins associated with
a specific pathogenic mechanism of action using the
Figure 2 (See legend on next page.)
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Figure 2 Secretion systems search results. (A) A search for B. mallei (strain ATCC 23344) type 3 secretion system proteins yields a list of
pathogen proteins associated with that secretion system. The content of the list can be filtered by cluster type and mechanisms of action, e.g., by
the animal-associated T3SS cluster and the actin cytoskeleton rearrangement mechanism. (B) The genome browser shows the location of the
bacterial proteins associated with the secretion system on the bacterial reference sequence. (C) Users can visualize host-pathogen protein-protein
interactions (PPIs) with the help of the PPI browser. Interactions are represented in the form of networks, where proteins correspond to network
nodes (blue circles and red squares), and interactions between those proteins correspond to network edges (gray and green lines).
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The querying process for this application is similar to
the one for Application 2, and the result of a query is a
list of B. mallei proteins, their associated secretion sys-
tem types, and detailed information about their association
with the queried mechanism of action. The retrieved list
can be filtered by secretion system type. If host-B. mallei
interaction data are available for the listed B. mallei pro-
teins, DBSecSys also retrieves their corresponding host-
pathogen PPIs.
Application 4: Host-pathogen interactions associated with
secretion systems
DBSecSys allows users to browse all available host-
pathogen interactions in the database using the “Host-
Pathogen Interactions” page. This page gives users an
option to retrieve host-specific interactions or all host-B.
mallei interactions. Additionally, this page allows users to
select the type of interactions they want to retrieve – only
experimentally detected PPIs (the default option) or ex-
perimentally detected and computationally predicted PPIs.
The resulting list of host-B. mallei interactions can be fil-
tered based on host and pathogen protein names. Subsets
of host-B. mallei PPIs can also be accessed through mul-
tiple other pages on the DBSecSys Web interface, e.g.,
through searches by protein, secretion system, or mecha-
nisms of action.
Application 5: Experimentally screened virulence factors
associated with secretion systems
DBSecSys contains detailed information about B. mallei
secretion system proteins tested for virulence attenuation
(by genetic ablation) in animal model experiments, which
can be queried using the “Virulence Attenuation” page
on the Web interface. The resulting list of proteins con-
tains information about the virulence attenuation level,
animal model and infection route used, and the associ-
ated secretion system type. Users can filter the list of pro-
teins based on the secretion system type, animal model,
and infection route.
Data visualization
The DBSecSys Web interface provides two visualization
tools: 1) an interactive genome browser for displaying
pathogen genes on the reference sequence and 2) aninteractive network visualization tool for displaying host-
pathogen PPIs.
Figure 2B shows the genome browser that displays the
B. mallei reference sequence and highlights the chromo-
somal location of secretion system genes and gene clusters,
allowing users to locate the positions of genes associated
with the secretion systems and interactively explore differ-
ent parts of the sequence. It also enables users to study the
individual secretion system genes in the context of the ad-
jacent genes that are not associated with secretion systems,
and to study multiple genes that are part of a specific se-
cretion system or a secretion system cluster, or are associ-
ated with the same mechanism of action.
Figure 2C shows the PPI browser that provides visuali-
zation of host-pathogen PPIs in the form of networks,
where proteins are represented as network nodes and in-
teractions between proteins are represented as network
edges. Visualization of host-pathogen PPIs may help users
identify connectivity patterns underlying these interactions.
By default, the PPI browser displays the interactions using
a circular breadth-first search layout. However, users can
choose one of the provided layout options (breadth first
linear, circle, and force-directed arbor layouts) or inter-
actively move and rearrange all nodes and edges. The PPI
browser also allows users to select additional visualization
options, e.g., to display or hide computationally predicted
PPIs and to visualize the interactions between host proteins
by displaying host PPIs.
Both tools provide zoom in/out options and the ability
to save the resulting view as an image. Additionally,
visualization tools provide contextual pop-up displays
that allow users to efficiently retrieve more information
about proteins directly from the visualization tools, e.g.,
information provided by NCBI (genome browser) or in-
formation about the protein secretion system type and
virulence attenuation (PPI browser).
Database updates
The database content will be updated periodically to in-
clude new experimental and computational evidence.
Additionally, the database will be expanded to include
additional pathogens, their corresponding secretion sys-
tems, mechanisms of action, and virulence attenuation
information. Before each update, the current state of the
database will be frozen and archived.
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We developed a curated database of bacterial secretion
system proteins and their host factors. Currently, the
database contains comprehensive information about
B. mallei proteins associated with secretion systems, their
involvement in virulence, their host targets (proteins), and
their mechanisms of action inferred from literature and
host-pathogen interaction data. Systematical organization
of experimental and computational data allows for efficient
data retrieval, browsing, querying, and visualization, and
enables users to study secretion systems not only through
characterization of the corresponding pathogen proteins
but also through characterization of host-interacting part-
ners. Together, these features make DBSecSys a unique re-
source for B. mallei secretion system research.
Availability and requirements
The Web-enabled DBSecSys database is freely accessible
at https://applications.bhsai.org/dbsecsys. The DBSecSys
Web interface has been tested in the following Web
browsers: Google Chrome (version 31), Microsoft Internet
Explorer (version 10), and Mozilla Firefox (version 25).
The “User Guide” page of the DBSecSys Web interface in-
cludes a step-by-step description of all DBSecSys features.
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